An illuminated Ram Mandir on the first anniversary of the Pran Pratishtha ceremony on January 11. (File image)(HT File) Bestowed with the title of 'Gaddi Nasheen,' Mahant Prem Das is 70 years old ...

Ram Janmabhoomi Path – 2 km from Sugriv Quila to Ram Mandir, and Bhakti Path- 850 metres from Shringar Hat to Sri Ram Janmabhoomi.

This particular model comes with an Intel Core i5-12450H processor and a solid 24GB of LPDDR5 RAM, a smooth combination that offers good performance and power efficiency without breaking the bank.

For most Indians, Ramayana is not just an epic—it’s an emotional compass, a moral guide, and a living tradition. But what if ...

Ram Charan’s political drama, Game Changer, failed to impress at the box office, but its Hindi version is set for an OTT release. The film is already available on Amazon Prime Video in Telugu ...

Home IFSC code Bank Of India Delhi New Delhi Mandir Marg Check IFSC Code and MICR ... Vihar Punjabi Bagh Rajindra Place Rajouri Garden Ram Vihar Rohini C P Rohini Sector 24 Safdarjung Enclave ...

For the first time, Hanumangarhi Temple's chief priest Mahant Prem Das will step outside the temple to visit the Ram Mandir in Ayodhya on Akshay Tritya. Despite a centuries-old custom barring him from ...

Includes reviews of Marino Chrysler Jeep Dodge RAM from DealerRater. Want to share your experience with this dealership? Great team helped me get into my new lease. Great energy and no nonsense ...

Hanumangarhi Temple chief priest will leave his home for the first time to visit the nearby Ram Mandir on Akshay Tritya on April 30. Bestowed with the title of ’Gaddi Nasheen,’ Mahant Prem Das is 70 ...

Bestowed with the title of 'Gaddi Nasheen,' Mahant Prem Das is 70 years old and has never left the temple premises, which is spread over 52 bighas in Ayodhya.

In a momentous departure from a centuries-old tradition, Mahant Prem Das, the chief priest of the revered Hanumangarhi Temple in Ayodhya, is set to leave the temple premises for the first time on ...

Trump’s tariff threats have sent shockwaves through Indian pharma stocks, but analysts argue the real casualty could be the US healthcare system. With India supplying nearly half of US generics ...